JPRN-UMIN000032269已完成3 期
Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 4 With Combined Neurokinin-1 Receptor Antagonist, Palonosetron and Olanzapine in High- Emetogenic Chemotherapy - SPARED trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 281
研究概览
简要总结
Delayed CR rates in arm D4 and arm D1 were 79.7% and 75.0%, respectively (risk difference: -4.1%, 95% CI: -14.1% to 6.0%, P = 0.023). CR rates in arm D4 and arm D1 were 96.4% and 97.1%, (95% CI: -3.5% to 4.9%, P = 0.75) in the acute phase (0-24 h), and 79.0% and 72.8% (95% CI: -16.3% to 3.9%, P = 0.23) in the overall phase (0-120 h), respectively.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients taking systemic corticosteroid (oral and intravenous) 2) Patients taking antiemetics 3) Patients who receive moderately emetogenic chemotherapy within six days before and after cisplatin administration (Minimally to low emetogenic agents are allowed) 4) Patients who receive radiation therapy to abdomen or pelvis within six days prior to enrollment until six days after cisplatin 5) Patients with symptomatic brain metastasis 6) Patients who have diabetes mellitus with use of any antidiabetic or patients with HbA1c (NGSP) >= 6.5 7) Patients who have any convulsive disorder with medication
研究者
相似试验
已完成
4 期
A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse HeadacheMigraine HeadacheNCT03971071Amgen620
已完成
4 期
Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or LyricaHealthyNCT03179345Depomed32
已完成
不适用
A phase-IV randomised, double blind comparative evaluation of immunogenicity of Monovalent Type 1 Oral Poliomyelitis Vaccine (mOPV1) versus trivalent OPV (tOPV): four-armed studyISRCTN54186735Panacea Biotec Limited (India)720
已完成
3 期
Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee ReplacementArthroplasty, Replacement, KneeThromboembolismNCT00152971Boehringer Ingelheim2,615
Unknown
3 期
A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.Duodenal Ulcer,DUNCT04215653Sihuan Pharmaceutical Holdings Group Ltd.448
